Deanne Randolph has a long record of success in strategic marketing for leading biotech, pharmaceutical, and consumer-driven healthcare brands. From early development through launch, Deanne has led multiple US, European, and global initiatives along with several major pharmaceutical and biotechnology product launches.

Deanne’s ability to integrate professional, payer, and patient needs to identify growth-driving market strategies is particularly relevant in today’s competitive healthcare environment. She provides Sante Group clients expertise in strategic pre-launch planning, positioning, and targeting; life cycle management and clinical development strategy; global branding; medical education; and direct-to-consumer marketing.

Deanne has worked in both primary and secondary care across a broad range of therapeutic areas including immunology, oncology, rheumatology, neurology, pain and rare diseases. Prior to consulting, Deanne held brand management and commercial development positions at Pfizer, Johnson & Johnson, and Bayer. She holds both an MBA and a BA from Wake Forest University.

Chris Mathia is a proven medical device and digital health executive with a distinguished track record of leading turnaround efforts and delivering exceptional shareholder value. Based in Olathe, Kansas, he brings over two decades of healthcare technology leadership experience, specializing in acquisition-proven CEO tenures with deep roots in sales leadership.

Chris earned his Bachelor of Arts in Political Science from the University of Kansas and built his career foundation through progressive sales roles at leading medical device companies including Medline Industries, Aesculap/B.Braun, and Specialty Medical Systems before transitioning into healthcare technology leadership.

His most notable achievement came as CEO of Innara Health, where he led the organization through a comprehensive reorganization and recapitalization process that culminated in a successful acquisition by Cardinal Health, a Fortune 15 organization, in February 2023. Innara Health’s NTrainer solution holds the distinction of being the only FDA-cleared medical device clinically proven to improve feeding outcomes for newborns and infants born prematurely.

Marcella Garcia is a seasoned regulatory, quality, and compliance professional with extensive expertise in medical devices, Software as Medical Device (SaMD), and digital health technologies. Currently serving as a Principal Consultant working with multiple early-stage startups globally, she specializes in guiding companies through complex regulatory pathways while building robust quality management systems from the ground up.

Marcella earned her Bachelor of Science in Electrical and Computer Engineering from Vanderbilt University (1997-2001) and has continued her professional development with specialized certifications including Healthcare Information Security and Privacy Practitioner (HCISPP) from (ISC)², Certified SAFe Agile Scrum Master, and Cybersecurity for Managers from MIT Professional Education.

Her career is distinguished by her ability to thrive in the complex environments that startups inherently present, where rapid change, limited resources, and accelerated timelines are commonplace. She has a particular talent for guiding startups through the critical inflection point of building out their cross-functional teams, leveraging her focus on clear, direct, and honest communication to foster collaboration and drive organizations forward.

Jessica E. Foley is a dedicated senior regulatory professional with 18+ years of expertise and leadership in healthcare, due diligence, global biopharmaceutical development strategy, and regulatory submissions. As the Principal Consultant and Founder of Gaia Regulatory Sciences, LLC in Cambridge, MA, she provides strategic regulatory services and project management support for pharmaceutical and biotech companies worldwide.

Dr. Foley holds a Master of Science in Regulatory Affairs for Drugs, Biologics, & Medical Devices from Northeastern University (2009), a Graduate Certificate in Biopharmaceutical International Regulatory Affairs (2008), and a Bachelor of Arts in Psychology from the University of New Hampshire (2005). She is also a certified Regulatory Affairs Professional (RAC-Global) through the Regulatory Affairs Professionals Society (RAPS).

Dr. Raymond “Ray” Blanchard is a seasoned life sciences executive and current Entrepreneur-in-Residence at ARPA-H, bringing over two decades of experience in the life sciences tools industry. With deep technical expertise in genomics and extensive business development experience, Ray has established himself as a skilled navigator of the complexities within the diagnostics and research tools sectors.

Dr. Blanchard earned his Ph.D. in biochemistry/molecular biology from the University of California, Riverside. His academic foundation was strengthened through postdoctoral training in the Food Science & Human Nutrition Department at the University of Florida, where he later held a faculty research position and co-founded the department’s Nutritional Genomics Laboratory with Dr. Robert J. Cousins. His research contributions include numerous articles and book chapters on nutritional regulation of gene expression, novel gene/biomarker discovery, and mammalian zinc physiology.